(Q53849252)

20 May 2018

title

Acute vasodilator test in pulmonary arterial hypertension: evaluation of two response criteria. (English)

1 reference

20 May 2018

main subject

arterial hypertension

1 reference

6

1 reference

20 May 2018

Marcelo Britto Passos Amato

4

object named as

Marcelo Britto Passos Amato

1 reference

20 May 2018

Carlos Roberto Ribeiro de Carvalho

5

object named as

Carlos Roberto Ribeiro Carvalho

1 reference

20 May 2018

author name string

Eduardo Leite Vieira Costa

1

1 reference

20 May 2018

Carlos Jardim

2

1 reference

20 May 2018

Humberto Bassit Bogossian

3

1 reference

20 May 2018

publication date

1 September 2005

1 reference

20 May 2018

published in

Vascular Pharmacology

1 reference

20 May 2018

volume

43

1 reference

20 May 2018

issue

3

1 reference

20 May 2018

page(s)

143-147

1 reference

20 May 2018

Vasodilator therapy for primary pulmonary hypertension in children

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.05.004

Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.05.004

Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.05.004

Comparative acute effects of adenosine and prostacyclin in primary pulmonary hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.05.004

Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.05.004

Primary pulmonary hypertension. A national prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.05.004

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.05.004

Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.05.004

Pulmonary hypertension in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.05.004

Clinical classification of pulmonary hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.05.004

Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.05.004

Clinical and laboratory features of scleroderma patients with pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.05.004

10.1016/J.VPH.2005.05.004

7 January 2021

Identifiers

DOI

1 reference

20 May 2018

PubMed ID

16061423

1 reference

20 May 2018